moclobemide has been researched along with clorgyline in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (15.79) | 18.7374 |
1990's | 11 (19.30) | 18.2507 |
2000's | 12 (21.05) | 29.6817 |
2010's | 23 (40.35) | 24.3611 |
2020's | 2 (3.51) | 2.80 |
Authors | Studies |
---|---|
Agostinelli, E; Artico, M; Befani, O; De Martino, G; La Regina, G; Palumbo, M; Silvestri, R; Turini, P | 1 |
Agostinelli, E; Artico, M; Befani, O; La Regina, G; Lavecchia, A; Novellino, E; Silvestri, R; Turini, P | 1 |
Alcaro, S; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Cirilli, R; Ferretti, R; Granese, A; La Torre, F; Maccioni, E; Orallo, F; Ortuso, F; Secci, D; Yáñez, M | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Agostinelli, E; Befani, O; Gatti, V; La Regina, G; Lavecchia, A; Novellino, E; Silvestri, R; Turini, P | 1 |
Ercan, A; Jayaprakash, V; Sinha, BN; Ucar, G | 1 |
Erol, K; Gökhan-Kelekçi, N; Kendi, E; Koyunoğlu, S; Ozgen, O; Uçar, G; Yabanoğlu, S; Yelekçi, K; Yeşilada, A | 1 |
Alcaro, S; Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Orallo, F; Ortuso, F; Secci, D; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Chimenti, F; Chimenti, P; Fioravanti, R; Orallo, F; Ortuso, F; Rossi, F; Secci, D; Yáñez, M | 1 |
Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Orallo, F; Secci, D; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Chimenti, F; Chimenti, P; Cirilli, R; Ferretti, R; Fioravanti, R; Orallo, F; Ortuso, F; Rossi, F; Sanna, ML; Secci, D; Yáñez, M | 1 |
Alcaro, S; Borges, F; Gaspar, A; Milhazes, N; Orallo, F; Ortuso, F; Uriarte, E; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Cardia, MC; Carradori, S; Chimenti, F; Chimenti, P; Cirilli, R; Distinto, S; Ferretti, R; Granese, A; Kirchmair, J; Langer, T; Maccioni, E; Orallo, F; Ortuso, F; Secci, D; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Orallo, F; Ortuso, F; Secci, D; Yáñez, M | 1 |
Alcaro, S; Cardia, MC; Costa, G; Distinto, S; Maccioni, E; Meleddu, R; Orallo, F; Sanna, ML; Secci, D; Vigo, S; Yanez, M | 1 |
Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Cirilli, R; Gallinella, B; Granese, A; Orallo, F; Sanna, ML; Secci, D; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Fioravanti, R; Manna, F; Orallo, F; Ortuso, F; Rossi, F; Vitali, A; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Desideri, N; Fioravanti, R; Monaco, LP; Orallo, F; Ortuso, F; Yáñez, M | 1 |
Alcaro, S; Bolasco, A; Carradori, S; Chimenti, P; Ortuso, F; Secci, D; Yáñez, M | 1 |
Escobar, M; García-Mera, X; González-Díaz, H; Prado-Prado, F; Riera-Fernandez, P; Sobarzo-Sánchez, E; Yañez, M | 1 |
Alcaro, S; Bolasco, A; Cardia, MC; Distinto, S; Gaspari, M; Kirchmair, J; Maccioni, E; Markt, P; Meleddu, R; Ortuso, F; Sanna, ML; Secci, D; Wolber, G; Yáñez, M | 1 |
Abdalla, MM; Abdelhafez, OM; Ali, HI; Amin, KM; Batran, RZ | 1 |
Bolasco, A; Carradori, S; D'Ascenzio, M; Nescatelli, R; Secci, D; Yáñez, M | 1 |
Alcaro, S; Biava, M; Desideri, N; Fioravanti, R; Ortuso, F; Proietti Monaco, L; Yáñez, M | 2 |
Biava, M; Desideri, N; Fioravanti, R; Grammatica, L; Proietti Monaco, L; Yáñez, M | 1 |
Alcaro, S; Carradori, S; Cirilli, R; D'Ascenzio, M; De Monte, C; Mannina, L; Ortuso, F; Secci, D; Sobolev, AP; Yáñez, M | 1 |
Abdel Moneim, SA; Ali Ahmed, HE; Amer, A; Bekhit, AA; El Massry, AM; El-Faham, A; Hassan, SY; Khattab, SN | 1 |
Alam, MM; Alex, AT; Bansal, S; Chaudhary, A; Jaiswal, V; Joseph, A; Suthar, SK; Tiwari, A | 1 |
Alcaro, S; Arridu, A; Bianco, G; Cirilli, R; Cossu, P; Cottiglia, F; Distinto, S; Faggi, C; Maccioni, E; Meleddu, R; Ortuso, F; Sanna, ML; Yanez, M | 1 |
Borges, F; Delogu, GL; Fontenla, JA; Hripcsak, G; Matos, MJ; Mayán, L; Munín, J; Pintus, F; Vilar, S; Viña, D | 1 |
Acar Çevik, U; Kaplancıklı, ZA; Kaya Çavuşoğlu, B; Levent, S; Osmaniye, D; Özkay, Y; Sağlık, BN | 1 |
Bai, R; Jiang, X; Wu, K; Zhang, P; Zhang, Y | 1 |
Antonin, KH; Bieck, PR; Gleiter, CH; Mühlbauer, B; Nilsson, E | 1 |
Iwata, N; Kumagae, Y; Matsui, Y | 1 |
Stöcklin, K; Waldmeier, PC | 1 |
Fletcher, PJ; Yu, PH | 1 |
Rényi, L | 1 |
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
Bizière, K; Kan, JP; Mouget-Goniot, C; Steinberg, R; Worms, P | 1 |
Cesura, AM; Da Prada, M; Kettler, R; Richards, JG | 1 |
Finberg, JP; Youdim, MB | 1 |
Dowson, JH | 1 |
Demurov, EA; Gol'dina, OA; Koloskov, IuB; Tepliakov, VG; Zagorevskiĭ, VA | 1 |
Waldmeier, PC | 1 |
McIntyre, IM; Oxenkrug, GF; Requintina, PJ; White, K | 1 |
Youdim, MB | 1 |
Finberg, JP | 1 |
Alemany, R; García-Sevilla, JA; Olmos, G | 1 |
Gerardy, J | 1 |
Finberg, JP; Lavian, G; Youdim, MB | 1 |
Ametamey, SM; Antonini, A; Beer, HF; Guenther, I; Leenders, KL; Schubiger, PA; Waldmeier, PC | 1 |
Hibell, A; Hudson, AL; Lalies, MD; Nutt, DJ | 1 |
Bonnet, U; Leniger, T; Wiemann, M | 1 |
Culver, KE; Rosenfeld, JM; Szechtman, H | 1 |
Bejar, C; Drigues, N; Poltyrev, T; Weinstock, M; Youdim, MB | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
4 review(s) available for moclobemide and clorgyline
Article | Year |
---|---|
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Topics: Animals; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Antiviral Agents; Drug Development; Heterocyclic Compounds; Humans; Hypoglycemic Agents; Mice; Neuroprotective Agents; Photochemotherapy; Quinoxalines; Structure-Activity Relationship; Tubulin Modulators | 2022 |
MAO inhibitors in mental disease: their current status.
Topics: Benzamides; Clorgyline; Depressive Disorder; Drug Therapy, Combination; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine; Tranylcypromine | 1987 |
The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
Topics: Benzamides; Cheese; Clorgyline; Depressive Disorder; Humans; Hypertension; Moclobemide; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 1995 |
Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
Topics: Animals; Benzamides; Clorgyline; Dopamine; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Piperidines; Rats; Serotonin; Sympathetic Nervous System; Tyramine | 1995 |
53 other study(ies) available for moclobemide and clorgyline
Article | Year |
---|---|
Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
Topics: Alkynes; Amides; Amines; Animals; Brain; Cattle; Isoenzymes; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrroles; Structure-Activity Relationship | 2003 |
New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Topics: Animals; Benzylamines; Binding Sites; Brain; Cattle; In Vitro Techniques; Isoenzymes; Mitochondria; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2007 |
Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones.
Topics: Chromatography, High Pressure Liquid; Cyclohexanones; Humans; Hydrazones; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Thermodynamics; Thiazoles; Thiosemicarbazones | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
Topics: Binding Sites; Indoles; Kinetics; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship | 2008 |
Pyrazoline-based mycobactin analogues as MAO-inhibitors.
Topics: Acetamides; Animals; Binding Sites; Catalytic Domain; Drug Design; Humans; Inhibitory Concentration 50; Linezolid; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Pyrazoles; Rats; Siderophores | 2008 |
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Topics: Binding Sites; Flavin-Adenine Dinucleotide; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles; Quinazolinones | 2009 |
Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Topics: Coumarins; Crystallography, X-Ray; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2009 |
Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Topics: Chalcones; Crystallography, X-Ray; Databases, Protein; Drug Design; Humans; Inhibitory Concentration 50; Isoenzymes; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2009 |
Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Topics: Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles | 2010 |
A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
Topics: Flavanones; Flavones; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Sulfhydryl Compounds | 2010 |
Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
Topics: Binding Sites; Chromones; Computer Simulation; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Isoforms | 2010 |
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
Topics: Chromatography, High Pressure Liquid; Humans; Hydrazones; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship; Thiazoles | 2010 |
Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
Topics: Humans; Hydrazines; Hydrogen Peroxide; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2010 |
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
Topics: Animals; Cell Line; Humans; Insecta; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Pyrazoles; Recombinant Proteins; Structure-Activity Relationship; Thioamides | 2010 |
Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines.
Topics: Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Hydrazines; Isoenzymes; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2010 |
Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
Topics: Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prenylation; Pyrazoles; Structure-Activity Relationship | 2010 |
Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties.
Topics: Drug Discovery; Flavonoids; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Conformation; Substrate Specificity | 2011 |
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Topics: Coumarins; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2011 |
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Topics: Antiprotozoal Agents; Aporphines; Databases, Factual; Humans; Ligands; Malaria, Falciparum; Markov Chains; Models, Biological; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Plasmodium falciparum; Protozoan Proteins; Quantitative Structure-Activity Relationship; Software; United States | 2011 |
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.
Topics: Binding Sites; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Dynamics Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Protein Conformation; Structure-Activity Relationship; Tandem Mass Spectrometry; Thiazoles | 2012 |
Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
Topics: Coumarins; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Spectrophotometry, Infrared | 2012 |
Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.
Topics: Dose-Response Relationship, Drug; Humans; Hydrazines; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2012 |
1,5-Diphenylpenta-2,4-dien-1-ones as potent and selective monoamine oxidase-B inhibitors.
Topics: Cells, Cultured; Curcumin; Enzyme Activation; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase Inhibitors; Quantum Theory; Structure-Activity Relationship | 2013 |
Design, synthesis, and in vitro hMAO-B inhibitory evaluation of some 1-methyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles.
Topics: Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Molecular Structure; Monoamine Oxidase; Pyrazoles; Structure-Activity Relationship | 2013 |
Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors.
Topics: Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Design; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2014 |
Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
Topics: Animals; Catalytic Domain; Cattle; Chemistry Techniques, Synthetic; Drug Design; Humans; Male; Mice; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quinoxalines; Stereoisomerism; Structure-Activity Relationship | 2015 |
Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
Topics: Animals; Antidepressive Agents; Benzylidene Compounds; Clorgyline; Imipramine; Indoles; Lactams; Mice; Moclobemide; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2015 |
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold.
Topics: Computer Simulation; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Dynamics Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Structure-Activity Relationship | 2016 |
(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
Topics: Chromans; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Sensitivity and Specificity; Solvents; Structure-Activity Relationship | 2016 |
MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis,
Topics: | 2017 |
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.
Topics: | 2020 |
Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
Topics: Adult; Benzamides; Blood Platelets; Clorgyline; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Piperidines | 1992 |
Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
Topics: Animals; Benzamides; Biogenic Monoamines; Brain; Cerebral Cortex; Clorgyline; Corpus Striatum; Deamination; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pyrimidines; Rats; Rats, Inbred Strains; Selegiline; Serotonin | 1991 |
Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
Topics: Animals; Benzamides; Binding, Competitive; Biogenic Monoamines; Clorgyline; In Vitro Techniques; Male; Microsomes, Liver; Moclobemide; Monoamine Oxidase; Piperidines; Proadifen; Propylamines; Rats; Rats, Inbred Strains; Tissue Distribution | 1990 |
Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
Topics: Animals; Benzamides; Clorgyline; Drug Synergism; Feeding Behavior; Male; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
Topics: Animals; Benzamides; Clorgyline; Dose-Response Relationship, Drug; Ejaculation; Male; Methoxydimethyltryptamines; Moclobemide; Monoamine Oxidase Inhibitors; Nialamide; p-Chloroamphetamine; Pargyline; Rats; Receptors, Serotonin; Selegiline; Serotonin; Time Factors | 1986 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Topics: Animals; Benzamides; Biogenic Amines; Brain; Clorgyline; Dopamine; Duodenum; Harmaline; Isoenzymes; Liver; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Pyridazines; Rats; Selegiline; Synaptosomes | 1987 |
Reversible, enzyme-activated monoamine oxidase inhibitors: new advances.
Topics: Animals; Benzamides; Brain; Clorgyline; Humans; In Vitro Techniques; Male; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Picolinic Acids; Piperidines; Rats; Selegiline | 1988 |
Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase.
Topics: Animals; Benzamides; Blood Pressure; Clorgyline; Drug Synergism; Male; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Phenethylamines; Piperidines; Rats; Rats, Inbred Strains; Tyramine | 1988 |
[Effect of benzamide derivatives on convulsions induced by the toxic action of oxygen in rats].
Topics: Animals; Anticonvulsants; Benzamides; Brain; Clorgyline; Drug Evaluation, Preclinical; Heart; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxygen; Rats; Seizures | 1987 |
On the reversibility of reversible MAO inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Brain; Clorgyline; Dopamine; Female; Homovanillic Acid; Kinetics; Liver; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Phenethylamines; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1985 |
Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
Topics: Animals; Benzamides; Clorgyline; Female; Hydroxyindoleacetic Acid; Melatonin; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pineal Gland; Rats; Rats, Inbred F344; Serotonin; Time Factors | 1994 |
The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Benzamides; Binding, Competitive; Brain; Chlorphenamidine; Clorgyline; Cytochrome P-450 Enzyme System; Dioxanes; Idazoxan; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Injections, Intraperitoneal; Isocarboxazid; Liver; Male; Moclobemide; Monoamine Oxidase Inhibitors; Pargyline; Phenelzine; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Tranylcypromine | 1995 |
Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Topics: Animals; Benzamides; Brain; Clorgyline; Harmaline; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar | 1994 |
The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
Topics: Animals; Antidepressive Agents; Benzamides; Blood Pressure; Clorgyline; Desipramine; Heart Rate; Kidney; Moclobemide; Monoamine Oxidase Inhibitors; Piperidines; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1993 |
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.
Topics: Animals; Benzamides; Brain; Carbon Radioisotopes; Clorgyline; Female; Hydrocarbons, Iodinated; Indicators and Reagents; Isoenzymes; Isotope Labeling; Macaca mulatta; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Tomography, Emission-Computed | 1996 |
Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
Topics: Animals; Benzamides; Binding Sites; Brain; Clorgyline; Imidazoles; Imidazoline Receptors; Isoenzymes; Kinetics; Ligands; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Rats; Receptors, Drug; Selegiline; Serotonin | 1999 |
Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices-implication for its neuroprotective properties.
Topics: Action Potentials; Animals; Clorgyline; Guinea Pigs; Hippocampus; Hydrogen-Ion Concentration; Moclobemide; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents | 2000 |
A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Clorgyline; Dopamine; Dopamine Agonists; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Neostriatum; Quinpirole; Rats; Rats, Long-Evans; Serotonin; Stereotyped Behavior | 2000 |
cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs.
Topics: Activating Transcription Factor 1; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Clorgyline; Cyclic AMP; DNA Primers; DNA-Binding Proteins; DNA, Complementary; Hippocampus; Male; Moclobemide; Oligonucleotide Array Sequence Analysis; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factors | 2003 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |